Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
Apply
GCD with [18F]FTT
[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step